Cumulatively, our data underline GCT as immunologically “hot” tumor, heavily infiltrated by T cells, which can be expanded and reinvigorate (64) in vitro, preserving their antitumor activity and their ability to target FOXL2 antigen. The gene discussed is FOXL2; the disease is neoplasm.